27.07.2011 • News

Strong Franc hits Lonza's Profit

Lonza reported Wednesday that its first-half profit fell 28% to 97 million Swiss francs or 1.89 francs per share from 135 million francs or 2.61 francs a year ago.

Core profit, which excluded items, dropped 23% to 107 million francs or 2.08 francs per share.

For the first half, sales fell 8.3% to 1.19 billion francs from 1.30 billion francs last year, due to strong negative currency exchange rate impacts. At constant exchange rate, revenue grew 4.8% with strong performance in Biological Custom Manufacturing and Development Services. Looking ahead, the company said it remains on track to deliver continued growth for the full year, despite ongoing market volatility combined with macro-economic uncertainties.

 

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read